Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,919,013
-$20,820,207 QoQ
Shares Held
426,592
-54.3% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#100
of 646 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. RPRX ranks #15 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,919,013 | 426,592 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $44,739,220 | 932,650 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,537,269 | 790,302 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $28,465,738 | 806,852 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $26,699,527 | 741,036 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,712,944 | 279,889 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,356,360 | 209,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,974,253 | 211,179 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,527,623 | 171,696 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,389,672 | 177,467 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,646,784 | 129,825 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,333,361 | 122,821 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,899,679 | 842,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,375,428 | 870,814 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,216,452 | 1,144,141 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,238,664 | 677,916 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,124,712 | 98,114 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,560,359 | 91,385 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,030,158 | 50,945 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $103,704 | 2,530 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,391,478 | 31,900 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $578,377 | 11,556 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $70,467 | 1,675 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||